Related Experiment Video
Updated: Jan 19, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell
Megan M Hanlon1, Tatsiana Rakovich1, Clare C Cunningham1
1Molecular Rheumatology, Trinity Biomedical Sciences Institute, TCD, Dublin, Ireland.
Abstract:
Objectives: Oncostatin M (OSM), a pleiotropic cytokine and a member of the gp130/IL-6 cytokine family, has been implicated in the pathogenesis of autoimmune diseases. Here we investigate the mechanisms by which its synergistic interactions with TNFα regulate the cellular bioenergetics and invasive function of synovial cells from patients with Rheumatoid Arthritis. Methods: Primary RA synovial fibroblasts (RAFLS) and human umbilical vein endothelial cells (HUVEC) were cultured with OSM alone or in combination with TNFα. Pro-inflammatory cytokines, angiogenic growth factors and adhesion molecules were quantified by real-time PCR and ELISA. Invasion, angiogenesis and cellular adhesion were quantified by Transwell invasion chambers, Matrigel tube formation assays, and adhesion binding assays. Cellular bioenergetics was assessed using the Seahorse XFe96 Analyser. Key metabolic genes (GLUT-1, HK2, PFKFB3, HIF1α, LDHA, PKM2) and transcription factor STAT3 were measured using real-time PCR and western blot. Results: OSM differentially regulates pro-inflammatory mediators in RAFLS and HUVEC, with IL-6, MCP-1, ICAM-1, and VEGF all significantly induced, in contrast to the observed inhibition of IL-8 and GROα, with opposing effects observed for VCAM-1 depending on cell type. Functionally, OSM significantly induced angiogenic network formation, adhesion, and invasive mechanisms. This was accompanied by a change in the cellular bioenergetic profile of the cells, where OSM significantly increased the ECAR/OCR ratio in favor of glycolysis, paralleled by induction of the glucose transporter GLUT-1 and key glycolytic enzymes (HK2, PFKFB3, HIF1α). OSM synergizes with TNFα to differentially regulate pro-inflammatory mechanisms in RAFLS and HUVEC. Interestingly, OSM differentially synergizes with TNFα to regulate metabolic reprogramming, where induction of glycolytic activity with concomitant attenuation of mitochondrial respiration and ATP activity was demonstrated in RAFLS but not in HUVEC. Finally, we identified a mechanism, whereby the combination of OSM with TNFα induces transcriptional activity of STAT3 only in RAFLS, with no effect observed in HUVEC. Conclusion: STAT3 mediates the differential effects of OSM and TNFα on RAFLS and EC function. Targeting OSM or downstream signaling pathways may lead to new potential therapeutic or adjuvant strategies, particularly for those patients who have sub-optimal responses to TNFi.
Insights
Oncostatin M (OSM) and TNFα synergistically alter cellular energy and invasion in Rheumatoid Arthritis synovial cells. STAT3 activation in these cells drives differential effects, suggesting new therapeutic targets for TNFi-resistant patients.
Area of Science:
- Immunology
- Cell Biology
- Metabolic Research
Background:
- Autoimmune diseases like Rheumatoid Arthritis (RA) involve complex cytokine signaling.
- Oncostatin M (OSM), a gp130/IL-6 family cytokine, is implicated in RA pathogenesis.
- Understanding OSM's role in RA synovial cell function is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate how Oncostatin M (OSM) interacts with TNFα to regulate cellular bioenergetics and invasive functions in Rheumatoid Arthritis (RA) synovial cells.
- To elucidate the specific mechanisms, including metabolic reprogramming and STAT3 activation, underlying these interactions.
- To identify potential therapeutic targets for RA, especially for patients unresponsive to TNF inhibitors (TNFi).
Main Methods:
- Primary RA synovial fibroblasts (RAFLS) and human umbilical vein endothelial cells (HUVEC) were treated with OSM alone or with TNFα.
- Gene and protein expression (cytokines, adhesion molecules, metabolic genes, STAT3) were analyzed using real-time PCR and Western blot.
- Cellular functions including invasion, angiogenesis, and adhesion were assessed using functional assays.
- Cellular bioenergetics (glycolysis vs. mitochondrial respiration) were measured using Seahorse XF analysis.
Main Results:
- OSM differentially regulated pro-inflammatory mediators and adhesion molecules in RAFLS and HUVEC.
- OSM promoted angiogenesis, adhesion, and invasion, altering cellular bioenergetics towards glycolysis (increased ECAR/OCR ratio, GLUT-1, HK2, PFKFB3, HIF1α).
- OSM and TNFα synergistically induced STAT3 transcriptional activity specifically in RAFLS, leading to metabolic reprogramming (glycolysis increase, mitochondrial respiration decrease), but not in HUVEC.
Conclusions:
- STAT3 mediates the differential effects of OSM and TNFα on RAFLS and endothelial cell (EC) function.
- Targeting OSM or its downstream signaling pathways, particularly STAT3, offers potential therapeutic or adjuvant strategies for RA.
- These strategies may benefit patients with suboptimal responses to current TNFi therapies.
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

